These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15942701)

  • 61. Prevalence of first-step mutants among levofloxacin-susceptible isolates of Streptococcus pneumoniae in north Lebanon.
    Dabboussi F; Allouche S; Mallat H; Hamze M
    J Chemother; 2013 Dec; 25(6):328-31. PubMed ID: 24091419
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Primary targets of fluoroquinolones in Streptococcus pneumoniae.
    Fukuda H; Hiramatsu K
    Antimicrob Agents Chemother; 1999 Feb; 43(2):410-2. PubMed ID: 9925547
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Characterization of a mutation in the parE gene that confers fluoroquinolone resistance in Streptococcus pneumoniae.
    Perichon B; Tankovic J; Courvalin P
    Antimicrob Agents Chemother; 1997 May; 41(5):1166-7. PubMed ID: 9145891
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Emergence of quinolone-resistant strains in Streptococcus pneumoniae isolated from paediatric patients since the approval of oral fluoroquinolones in Japan.
    Takeuchi N; Ohkusu M; Hoshino T; Naito S; Takaya A; Yamamoto T; Ishiwada N
    J Infect Chemother; 2017 Apr; 23(4):218-223. PubMed ID: 28159338
    [TBL] [Abstract][Full Text] [Related]  

  • 65. An extended PCR-RFLP assay for detection of parC, parE and gyrA mutations in fluoroquinolone-resistant Streptococcus pneumoniae.
    Alonso R; Galimand M; Courvalin P
    J Antimicrob Chemother; 2004 Apr; 53(4):682-3. PubMed ID: 15014061
    [No Abstract]   [Full Text] [Related]  

  • 66. Pharmacodynamic characterization of efflux and topoisomerase IV-mediated fluoroquinolone resistance in Streptococcus pneumoniae.
    Madaras-Kelly KJ; Daniels C; Hegbloom M; Thompson M
    J Antimicrob Chemother; 2002 Aug; 50(2):211-8. PubMed ID: 12161401
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Activities of newer fluoroquinolones against ciprofloxacin-resistant Streptococcus pneumoniae.
    Coyle EA; Kaatz GW; Rybak MJ
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1654-9. PubMed ID: 11353608
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Molecular mechanisms of decreased susceptibility to fluoroquinolones in avian Salmonella serovars and their mutants selected during the determination of mutant prevention concentrations.
    Kehrenberg C; de Jong A; Friederichs S; Cloeckaert A; Schwarz S
    J Antimicrob Chemother; 2007 May; 59(5):886-92. PubMed ID: 17369276
    [TBL] [Abstract][Full Text] [Related]  

  • 69. New mutation in parE in a pneumococcal in vitro mutant resistant to fluoroquinolones.
    Janoir C; Varon E; Kitzis MD; Gutmann L
    Antimicrob Agents Chemother; 2001 Mar; 45(3):952-5. PubMed ID: 11181389
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Interspecies recombination contributes minimally to fluoroquinolone resistance in Streptococcus pneumoniae.
    Bast DJ; de Azavedo JC; Tam TY; Kilburn L; Duncan C; Mandell LA; Davidson RJ; Low DE
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2631-4. PubMed ID: 11502541
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Molecular characterization of quinolone resistance-determining regions and their correlation with serotypes and genotypes among Streptococcus pneumoniae isolates in Japan.
    Osawa M; Ito Y; Ishida T; Imai S; Ichiyama S; Mishima M;
    Eur J Clin Microbiol Infect Dis; 2010 Feb; 29(2):245-8. PubMed ID: 19936985
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Viridans group streptococci are donors in horizontal transfer of topoisomerase IV genes to Streptococcus pneumoniae.
    Balsalobre L; Ferrándiz MJ; Liñares J; Tubau F; de la Campa AG
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2072-81. PubMed ID: 12821449
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Expression of efflux pump gene pmrA in fluoroquinolone-resistant and -susceptible clinical isolates of Streptococcus pneumoniae.
    Piddock LJ; Johnson MM; Simjee S; Pumbwe L
    Antimicrob Agents Chemother; 2002 Mar; 46(3):808-12. PubMed ID: 11850265
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Emergence of Haemophilus influenzae with low susceptibility to quinolones isolated from pediatric patients in Japan.
    Takeuchi N; Ohkusu M; Hoshino T; Yamamoto S; Segawa S; Murata S; Ishiwada N
    J Infect Chemother; 2021 Jul; 27(7):1020-1026. PubMed ID: 33658143
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prevalence of a putative efflux mechanism among fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae.
    Brenwald NP; Gill MJ; Wise R
    Antimicrob Agents Chemother; 1998 Aug; 42(8):2032-5. PubMed ID: 9687402
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Real-time PCR detection of gyrA and parC mutations in Streptococcus pneumoniae.
    Page S; Vernel-Pauillac F; O'Connor O; Bremont S; Charavay F; Courvalin P; Goarant C; Le Hello S
    Antimicrob Agents Chemother; 2008 Nov; 52(11):4155-8. PubMed ID: 18725440
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Phenotypic and molecular characterization of fluoroquinolone resistant Pseudomonas aeruginosa isolates in Palestine.
    Adwan G; Omar G
    Braz J Biol; 2021; 82():e239868. PubMed ID: 34190800
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Characterization of clinical Streptococcus pneumoniae strains from Germany with decreased susceptibility to fluoroquinolones.
    Reinert RR; Al-Lahham A; Lütticken R; Boos M; Schmitz FJ
    J Antimicrob Chemother; 2002 Jun; 49(6):1015-8. PubMed ID: 12039895
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Changes in fluoroquinolone-resistant Streptococcus pneumoniae after 7-valent conjugate vaccination, Spain.
    de la Campa AG; Ardanuy C; Balsalobre L; Pérez-Trallero E; Marimón JM; Fenoll A; Liñares J
    Emerg Infect Dis; 2009 Jun; 15(6):905-11. PubMed ID: 19523289
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Screening of large numbers of Streptococcus pneumoniae isolates for mutations associated with fluoroquinolone resistance using an oligonucleotide probe assay.
    Davies TA; Goldschmidt R
    FEMS Microbiol Lett; 2002 Dec; 217(2):219-24. PubMed ID: 12480107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.